Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs Prednisone in Pulmonary Sarcoidosis
NCT04314193Phase 4Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2020
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methotrexate in pulmonary sarcoidosis, sponsored by Erasmus MC. Started Jun 2020; status: active, not recruiting.
02
Drugs
methotrexate
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT04314193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04314193.